Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Beam Therapeutics Inc
(NQ:
BEAM
)
29.57
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
724
Open
29.57
Bid (Size)
29.06 (1)
Ask (Size)
29.99 (1)
Prev. Close
29.57
Today's Range
29.57 - 29.57
52wk Range
16.95 - 51.60
Shares Outstanding
79,199,501
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
Today 8:30 EST
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.
Via
The Motley Fool
Cathie Wood's ARK Innovation ETF Achieves 35% Gain In November, Its Best Month Since Inception
November 29, 2023
The ARK Innovation ETF (NYSE:ARKK), managed by renowned investor Cathie Wood, has posted remarkable gains in November, making it the fund’s best-performing month since its launch in 2014.
Via
Benzinga
Topics
ETFs
Performance
YTD
-20.77%
-20.77%
1 Month
+20.74%
+20.74%
3 Month
+24.87%
+24.87%
6 Month
-13.03%
-13.03%
1 Year
-33.36%
-33.36%
More News
Read More
The 3 Best Gene Editing Stocks on the Frontier of Medicine
November 20, 2023
Via
InvestorPlace
Is Beam Therapeutics Stock a Buy Now?
November 18, 2023
Via
The Motley Fool
Beam Therapeutics: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
Cathie Wood Loves This Beaten-Down Stock. But Is It in Trouble?
October 25, 2023
Via
The Motley Fool
3 Monster Stocks in the Making
November 18, 2023
Via
The Motley Fool
Right Now Could Be a Once-in-a-Generation Opportunity to Buy These Cathie Wood Stocks
November 14, 2023
Via
The Motley Fool
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 13, 2023
Via
Benzinga
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
November 08, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference
November 08, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners
November 06, 2023
Via
Investor's Business Daily
2 Magnificent Growth Stocks That Might Be Badly Mispriced Right Now
November 05, 2023
Via
The Motley Fool
Inside Cathie Wood’s Portfolio: 3 Stocks She Is Betting Millions On
November 01, 2023
Via
InvestorPlace
Why Beam and Verve Therapeutics Shares Soared While Eli Lilly Soured Today
October 31, 2023
Via
The Motley Fool
Verve Stock Soars On $250 Million Eli Lilly Deal
October 31, 2023
Via
Investor's Business Daily
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
October 31, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
After Cutting 20% of Its Staff, Is Beam Therapeutics Still a Buy?
October 31, 2023
Via
The Motley Fool
Why Beam Therapeutics Stock Is Getting Bought Today
October 31, 2023
Via
Benzinga
Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease
October 31, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Cathie Wood's Ark Invest Scoops Up More Than $3M Worth Of SoFi Technologies Shares Amid Q3 Earnings Beat From Online Lender
October 30, 2023
Via
Benzinga
Topics
Earnings
Exposures
Financial
5 Reasons Beam Therapeutics Remains a Risky Stock
October 30, 2023
Via
The Motley Fool
Beam Therapeutics Presents Preclinical Data Highlighting Utility and Durability of BEAM-301 to Correct a Glycogen Storage Disease Type I Deficiency Disease-Causing Mutation at ESGCT
October 25, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Textainer Group, Roivant Sciences And Other Big Stocks Moving Higher In Monday's Pre-Market Session
October 23, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
